Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yume Nagaoka

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 27, 2004
[Nephrotic syndrome and malignancy]Hiroshi Matsumoto, Yume Nagaoka
Renal Failure|January 13, 2015
Association between visit-to-visit clinic blood pressure variability and home blood pressure variability in patients with chronic kidney diseaseTomonari Okada, Toshikazu Wada, Yume Nagaoka, et al.
Blood Pressure Monitoring|December 21, 2011
Association of home blood pressure variability with progression of chronic kidney diseaseTomonari Okada, Hiroshi Matsumoto, Yume Nagaoka, et al.
Cardiorenal Medicine|May 20, 2016
Clinical Practice of Two Measurements of Home Blood Pressure on Each Occasion in Patients with Chronic Kidney DiseaseTomonari Okada, Toshikazu Wada, Yume Nagaoka, et al.
American Journal of Nephrology|July 19, 2008
Value of morning home blood pressure as a predictor of decline in renal function in patients with chronic kidney diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Clinical and Experimental Nephrology|February 9, 2011
Influence of erythropoietin-stimulating agent treatment on glycated hemoglobin values in diabetic patients with chronic kidney diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Nephrology (Carlton, Vic.)|September 22, 2011
Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuriaTomonari Okada, Toshitaka Nagao, Hiroshi Matsumoto, et al.
Nephrology (Carlton, Vic.)|February 26, 2013
Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysisHideaki Iwasawa, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Nephrology (Carlton, Vic.)|May 30, 2013
Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuriaTomonari Okada, Toshitaka Nagao, Hiroshi Matsumoto, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2009
Influence of age and nutritional status on glycated albumin values in hemodialysis patientsTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 27, 2004
[Nephrotic syndrome and malignancy]Hiroshi Matsumoto, Yume Nagaoka
Renal Failure|January 13, 2015
Association between visit-to-visit clinic blood pressure variability and home blood pressure variability in patients with chronic kidney diseaseTomonari Okada, Toshikazu Wada, Yume Nagaoka, et al.
Blood Pressure Monitoring|December 21, 2011
Association of home blood pressure variability with progression of chronic kidney diseaseTomonari Okada, Hiroshi Matsumoto, Yume Nagaoka, et al.
Cardiorenal Medicine|May 20, 2016
Clinical Practice of Two Measurements of Home Blood Pressure on Each Occasion in Patients with Chronic Kidney DiseaseTomonari Okada, Toshikazu Wada, Yume Nagaoka, et al.
American Journal of Nephrology|July 19, 2008
Value of morning home blood pressure as a predictor of decline in renal function in patients with chronic kidney diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Clinical and Experimental Nephrology|February 9, 2011
Influence of erythropoietin-stimulating agent treatment on glycated hemoglobin values in diabetic patients with chronic kidney diseaseTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Nephrology (Carlton, Vic.)|September 22, 2011
Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuriaTomonari Okada, Toshitaka Nagao, Hiroshi Matsumoto, et al.
Nephrology (Carlton, Vic.)|February 26, 2013
Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysisHideaki Iwasawa, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Nephrology (Carlton, Vic.)|May 30, 2013
Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuriaTomonari Okada, Toshitaka Nagao, Hiroshi Matsumoto, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2009
Influence of age and nutritional status on glycated albumin values in hemodialysis patientsTomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, et al.
Pageof 4